Selective pharmacological inhibition of Pan-PI3K and p110α effectively block transformations driven by partial p85α deletion in both in vitro and in vivo models, indicating that p85α functions as a tumor suppressor in transformation processes. This evidence concerns the gene PIK3CB and neoplasm.